Skip to search formSkip to main contentSkip to account menu

BRAHMA

Known as: BRM 
The Drosophila gene brahma (brm) encodes a non-specific RNA polymerase II transcription co-activator, assisting one or more transcriptional… 
National Institutes of Health

Related topics

Related topics

3 relations
Drosophila <fruit fly, genus>Drosophila SWI/SNFTRANSCRIPTION FACTOR

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
The CUE 1 domain of the SNF 2-like chromatin remodeler SMARCAD 1 mediates its association with KRAB-associated protein 1 ( KAP 1 ) and KAP 1 target genes
Chromatin in embryonic stem cells (ESCs) differs markedly from that in somatic cells, with ESCs exhibiting a more open chromatin… 
2018
2018
KONSEP PEMILIHAN NARASUMBER PADA DOKUMENTER “VIHARA MAHA BRAHMA DAN TOLERANSI” SEBAGAI PEMAHAMAN SOSIAL MASYARAKAT TENTANG SIKAP TOLERANSI
The documentary is a film based on fact or reality about someone's life or experience regarding events. In the documentary is the… 
2007
2007
Two Protein Kinases Required for ABA Signaling in Arabidopsis
  • N. Eckardt
  • The Plant Cell Online
  • 2007
  • Corpus ID: 28882479
Numerous studies have indicated that phosphorylation is an important component of ABA signaling. Fujii et al. (pages [485–494][1… 
2007
2007
A novel role of Brg1 in the regulation of SRF/MRTFA‐dependent smooth muscle‐specific genes
Serum Response Factor (SRF) has been shown to be a key regulator of smooth muscle (SM) differentiation, proliferation and… 
2003
2003
Evaluation of Anti-tumor property of Specific and Non-specific BRMs in Experimental Glioma by Assessing the Microglial Cell Functional and Phenotypic Modulations
Background: Microglial cells are considered to be the chief immunomodulatory cells of the brain. These cells play a crucial role… 
2002
2002
Antitumor effect of BRM
Objective: To evaluate the antitumor effect of BRM, a Chinese traditional medical compound herb, and its mechanism. Methods… 
2000
2000
Generation of monocyte-derived dendritic cells from patients with renal cell cancer: modulation of their functional properties after therapy with biological response modifiers (IFN-alpha plus IL-2…
The combination of interferon-alpha (IFN-alpha) plus interleukin (IL-2) has been accepted in the treatment of metastatic renal… 
1987
1987
[Prostaglandin E2 and interleukin-1-producing activity of plastic-adherent cells from cancer patients as a result of modification by BRM therapy].
It is crucial to define the immunological characteristics of peripheral blood mononuclear cells in order to clarify the… 
1984
1984
[Direct antitumor activity of biological response modifiers (B.R.M.) proven by an in vitro sensitivity test].
Although the role of biological response modifiers in cancer therapy is well recognised, their mechanism of action remains… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)